R78C/Matrix-M / University of Oxford 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
R78C/Matrix-M / University of Oxford
NCT05385471: A Phase Ia Clinical Trial to Assess the Safety and Immunogenicity of the Blood-stage Malaria Candidate Vaccines RH5.1 in Matrix-M and R78C in Matrix-M in Healthy UK Adults

Recruiting
1
36
Europe
Matrix M with R78C and/or RH5.1
University of Oxford
Malaria, Falciparum
07/24
07/24

Download Options